Pursuit of Product Quality Based on Safety and Usefulness Evaluations
First written in FY2016. 7 of 8 entries say "Restated". Latest entry: FY2025.
0 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「During product development, the Company conducts rigorous repeated-use assessments under the supervision of dermatologists, tailored to the characteristics of each product, in pursuit of a balance between safety and efficacy.」
Continues to balance safety and efficacy through supervision by dermatologists and repeated-use assessments. - FY2024RestatedAnnual report
「During product development, the Company conducts rigorous repeated-use assessments under the supervision of dermatologists, tailored to the characteristics of each product, in pursuit of a balance between safety and efficacy.」
Continues its product quality policy of balancing safety and efficacy through supervision by dermatologists and repeated-use assessments. - FY2022RestatedAnnual report
「The Company will continue to evaluate products based on various assessment methods and deliver products that offer high efficacy through application of the DDS concept and high safety that enables customers to use them with confidence.」
Continues its policy of balancing safety and efficacy through assessment methods and repeated-use assessments with specialists. - FY2021RestatedAnnual report
「The Company has conducted rigorous repeated-use assessments under the supervision of dermatologists, tailored to the characteristics of each product, in pursuit of a balance between safety and efficacy.」
Continues its policy of balancing safety and efficacy through supervision by specialists and repeated-use assessments. - FY2019RestatedAnnual report
「During product development, the Company conducts rigorous repeated-use assessments under the supervision of dermatologists, tailored to the characteristics of each product, in pursuit of a balance between safety and efficacy.」
Continues its policy of balancing safety and efficacy through supervision by specialists and rigorous repeated-use assessments. - FY2018RestatedAnnual report
「The Company will continue to evaluate products based on various assessment methods and deliver cosmetics that offer high efficacy through application of the DDS concept and high safety that enables customers to use them with confidence. The Company will also actively disseminate its research results externally through paper submissions and presentations at academic conferences in Japan and overseas.」
States its policy of continuing to balance safety and efficacy based on assessment methods and disseminate research results externally. - FY2017RestatedAnnual report
「The Company will continue to evaluate products based on appropriate assessment methods and deliver cosmetics that offer high efficacy through application of the DDS concept and high safety that enables customers to use them with confidence through to the end. The Company will also disseminate its research results externally through academic conferences and papers.」
The Company intends to continue balancing safety and efficacy based on assessment methods and disseminating research results externally. - FY2016First statedAnnual report
「The Company will continue to evaluate products based on appropriate assessment methods and deliver cosmetics that offer high efficacy through application of the DDS concept and high safety that enables customers to use them with confidence through to the end. The Company will also disseminate its research results externally through academic conferences and papers.」
The Company intends to continue balancing efficacy and safety, evaluating products based on assessment methods and disseminating research results externally.